100% Same
Salt CompositionEffectivenessStrength
with Substitute Medicine
Salt Composition in both
Our Recommendation
Tenepla M 500/20mg SR Tablet 10s
5,272+ trust this
WHO GMP Certified
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Delivery by
Used In
Treatment of Type 2 diabetes mellitus
Customers also bought
More About Tenezan-M Tablet PR
Side Effects
Side effects of Tenezan-M Tablet PRThe majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you�re worried about them Common side effects of Tenezan-MDiarrhea Nausea Vomiting Hypoglycemia (low blood glucose level)Decreased appetite Abdominal bloating Flatulence Constipation
How to use
How to use Tenezan-M Tablet PRUse it as advised by your doctor or check the label for directions before use. Tenezan-M Tablet PR is to be taken with food.
How it works
How Tenezan-M Tablet PR works Tenezan-M Tablet PR is a combination of two antidiabetic medicines:.
Unsafe: Avoid consuming alcohol with Tenezan-M Tablet PR as it is deemed unsafe.
Information regarding the use of Tenezan-M Tablet PR during pregnancy is not available. Doctor consultation is advised.
Information regarding the use of Tenezan-M Tablet PR during breastfeeding is not available. Doctor consultation is advised.
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Tenezan-M Tablet PR should be used with caution in patients with kidney disease. Dose adjustment of Tenezan-M Tablet PR may be needed. Doctor consultation is advised.Use of Tenezan-M Tablet PR is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Tenezan-M Tablet PR should be used with caution in patients with liver disease. Dose adjustment of Tenezan-M Tablet PR may be needed. Doctor consultation is advised.Tenezan-M Tablet PR is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
References
Metformin hydrochloride. Princeton, New Jersey: Bristol-Myers Squibb Company (08 Apr. 2019)
Kishimoto M. Teneligliptin: A DPP-4 inhibitor for the treatment of type 2 diabetes. Diabetes Metab Syndr Obes. 2013;6:187-95 (08 Apr. 2019)
Metformin hydrochloride oral solution. Gloversville, New York: Ranbaxy Pharmaceuticals Inc.; 2003 (08 Apr. 2019)
Teneligliptin and Metformin hydrochloride (20 Oct. 2021)
Teneligliptin and Metformin hydrochloride (20 Oct. 2021)
Teneligliptin and Metformin hydrochloride (20 Oct. 2021)
Teneligliptin and Metformin Hydrochloride ER (28th Sept. 2023)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
